Federico Ferrari, Nicolò Bizzarri, Anna Fagotti, Giovanni Scambia, Elisa Gozzini, Hooman Soleymani Majd, Matteo Rota, Franco Odicino
{"title":"妇科恶性肿瘤开放手术中早期不遵守 ERAS 和术后并发症:一项多中心、前瞻性、观察性队列研究。","authors":"Federico Ferrari, Nicolò Bizzarri, Anna Fagotti, Giovanni Scambia, Elisa Gozzini, Hooman Soleymani Majd, Matteo Rota, Franco Odicino","doi":"10.1136/ijgc-2024-005648","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Open surgical procedures for gynecological malignancies have a potential risk of post-operative complications and hence prolonged hospitalization, despite adherence to an Enhanced Recovery After Surgery (ERAS) protocol.</p><p><strong>Primary objective: </strong>To investigate the relationship between non-compliance to an ERAS protocol in the post-operative setting and the rate of post-operative complications, in women who underwent open surgery for gynecological malignancies.</p><p><strong>Study hypothesis: </strong>Early non-compliance with the ERAS protocol increases the risk of post-operative complications.</p><p><strong>Trial design: </strong>Multicenter, prospective, observational, cohort study.</p><p><strong>Major inclusion criteria: </strong>Patients with histologically proven gynecological cancer (endometrial, uterine, tubo-ovarian, and cervical) undergoing elective open surgery and managed according to ERAS guidelines.</p><p><strong>Exclusion criteria: </strong>Patients with post-operative recovery in an intensive care unit, undergoing anterior or total pelvic exenteration or intraperitoneal chemotherapy. Previous radiotherapy or previous non-gynecological major abdominal surgery.</p><p><strong>Primary endpoint: </strong>Association of non-compliance with the ERAS protocol using five selected indicators on post-operative day 2 with the rate of 30-day post-operative complications.</p><p><strong>Sample size: </strong>600 patients will be enrolled in the study.</p><p><strong>Estimated dates for completing accrual and presenting results: </strong>At present, 106 patients have been recruited. Based on this, the accrual should be completed in 2025. Results should be presented at the end of 2025.</p><p><strong>Trial registration: </strong>NCT05738902.</p>","PeriodicalId":14097,"journal":{"name":"International Journal of Gynecological Cancer","volume":" ","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Early non-compliance to ERAS in gynecological open surgery for malignancies, and post-operative complications: a multicenter, prospective, observational, cohort study.\",\"authors\":\"Federico Ferrari, Nicolò Bizzarri, Anna Fagotti, Giovanni Scambia, Elisa Gozzini, Hooman Soleymani Majd, Matteo Rota, Franco Odicino\",\"doi\":\"10.1136/ijgc-2024-005648\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Open surgical procedures for gynecological malignancies have a potential risk of post-operative complications and hence prolonged hospitalization, despite adherence to an Enhanced Recovery After Surgery (ERAS) protocol.</p><p><strong>Primary objective: </strong>To investigate the relationship between non-compliance to an ERAS protocol in the post-operative setting and the rate of post-operative complications, in women who underwent open surgery for gynecological malignancies.</p><p><strong>Study hypothesis: </strong>Early non-compliance with the ERAS protocol increases the risk of post-operative complications.</p><p><strong>Trial design: </strong>Multicenter, prospective, observational, cohort study.</p><p><strong>Major inclusion criteria: </strong>Patients with histologically proven gynecological cancer (endometrial, uterine, tubo-ovarian, and cervical) undergoing elective open surgery and managed according to ERAS guidelines.</p><p><strong>Exclusion criteria: </strong>Patients with post-operative recovery in an intensive care unit, undergoing anterior or total pelvic exenteration or intraperitoneal chemotherapy. Previous radiotherapy or previous non-gynecological major abdominal surgery.</p><p><strong>Primary endpoint: </strong>Association of non-compliance with the ERAS protocol using five selected indicators on post-operative day 2 with the rate of 30-day post-operative complications.</p><p><strong>Sample size: </strong>600 patients will be enrolled in the study.</p><p><strong>Estimated dates for completing accrual and presenting results: </strong>At present, 106 patients have been recruited. Based on this, the accrual should be completed in 2025. Results should be presented at the end of 2025.</p><p><strong>Trial registration: </strong>NCT05738902.</p>\",\"PeriodicalId\":14097,\"journal\":{\"name\":\"International Journal of Gynecological Cancer\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2024-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Gynecological Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/ijgc-2024-005648\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Gynecological Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-005648","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
Early non-compliance to ERAS in gynecological open surgery for malignancies, and post-operative complications: a multicenter, prospective, observational, cohort study.
Background: Open surgical procedures for gynecological malignancies have a potential risk of post-operative complications and hence prolonged hospitalization, despite adherence to an Enhanced Recovery After Surgery (ERAS) protocol.
Primary objective: To investigate the relationship between non-compliance to an ERAS protocol in the post-operative setting and the rate of post-operative complications, in women who underwent open surgery for gynecological malignancies.
Study hypothesis: Early non-compliance with the ERAS protocol increases the risk of post-operative complications.
Major inclusion criteria: Patients with histologically proven gynecological cancer (endometrial, uterine, tubo-ovarian, and cervical) undergoing elective open surgery and managed according to ERAS guidelines.
Exclusion criteria: Patients with post-operative recovery in an intensive care unit, undergoing anterior or total pelvic exenteration or intraperitoneal chemotherapy. Previous radiotherapy or previous non-gynecological major abdominal surgery.
Primary endpoint: Association of non-compliance with the ERAS protocol using five selected indicators on post-operative day 2 with the rate of 30-day post-operative complications.
Sample size: 600 patients will be enrolled in the study.
Estimated dates for completing accrual and presenting results: At present, 106 patients have been recruited. Based on this, the accrual should be completed in 2025. Results should be presented at the end of 2025.
期刊介绍:
The International Journal of Gynecological Cancer, the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach, and includes original research, reviews, and video articles. The audience consists of gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology.